Canada can be a leader in medical cannabis trade

There are millions of people worldwide with chronic diseases and other medical conditions whose lives could be improved with better access to medical cannabis. Meanwhile, for the past decade and a half, Canada has built the most sophisticated medical cannabis framework in the world. These circumstances present an exceptional opportunity for trade leadership on the international stage.

Last year, the amount spent on cannabis worldwide — including medical cannabis — was $150 billion. By comparison, Canada’s crude oil exports totalled $49.8 billion in 2016. The federal government must proactively make medical cannabis exports part of its innovation agenda. With the right approach, the industry has the potential to be a significant contributor to Canada’s biotechnology and life sciences sectors.

We should leverage the success of Canada’s domestic medical cannabis model to address the gap in access to quality products worldwide. Thanks to the Access to Cannabis for Medical Purposes Regulations (ACMPR)...

e-mail icon Facebook icon Twitter icon LinkedIn icon Reddit icon
Rate this article: